SAN DIEGO, Sept. 22, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento” or “Company”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the […]
LA JOLLA—Immunotherapy, which uses the body’s own immune system to fight cancer, is an effective treatment option, yet many patients do not respond to it. Thus, cancer researchers are seeking new ways to optimize immunotherapy […]
UC San Diego engineers have devised a new solution to control a major agricultural menace, root-damaging nematodes. Using plant viruses, they created nanoparticles that can deliver pesticides to previously unreachable soil depths. This could potentially […]
SAN FRANCISCO–(BUSINESS WIRE)– #biotech–Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner. Click here to view original post Click here to view San Diego Biotech Networks Trending […]
Breakthrough Properties is back keeping the dirt flying in biotech — this time breaking new ground in Amsterdam. The commercial real estate alliance between Tishman Speyer, which built Pfizer’s new world headquarters in Manhattan, and […]
Every year, without fail, the Endpoints 11 proves to be the most challenging project I face — and definitely remains the most fun. In an industry where ambition and zeal are trademarks of the most […]
Small molecule manufacturer Societal CDMO is laying off 9% of its employees — 26 positions — and terminating nine open roles to save around $5.5 million a year as part of its “strategic realignment.” The […]
SAN DIEGO, Sept. 20, 2023 /PRNewswire/ — Rady Children’s Hospital-San Diego, the largest children’s hospital on the West Coast and one of the nation’s top pediatric health care systems, and the University of California, San […]
Global Genes today announced the winners of its inaugural Xcelerate RARE Challenge Open Science Data Challenge at the RARE Advocacy Summit in San Diego. The Xcelerate RARE Challenge brought together academic and industry researchers and […]
Atara Biotherapeutics said Tuesday that it plans to submit its T cell immunotherapy for approval in the US next year. The therapy was approved last year in the EU, where it is marketed as Ebvallo. […]
© 2023 Biotech Networks, LLC
